39 related articles for article (PubMed ID: 11575742)
1. Hybrid capture as a means of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation.
Callaghan J; Karim S; Mortlock S; Wintert M; Woodward N
Br J Biomed Sci; 2001; 58(3):184-9. PubMed ID: 11575742
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
Jamison J; Wilson RT; Carson J
Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
4. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H;
Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
[TBL] [Abstract][Full Text] [Related]
8. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
9. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
[TBL] [Abstract][Full Text] [Related]
11. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
14. Novaprep(®) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2.
Prétet JL; Vidal C; Le Bail Carval K; Ramanah R; Carcopino X; Cartier I; Labouyrie E; Kantelip B; Coumes-Marquet S; Riethmuller D; Mougin C
J Clin Virol; 2010 Dec; 49(4):286-9. PubMed ID: 20884288
[TBL] [Abstract][Full Text] [Related]
15. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
[TBL] [Abstract][Full Text] [Related]
16. Development of optimal liquid based cytology sample processing methods for HPV testing: minimising the 'inadequate' test result.
Peevor R; Jones J; Fiander AN; Hibbitts S
J Virol Methods; 2011 May; 173(2):374-7. PubMed ID: 21295606
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus DNA and liquid-based cervical cytology cotesting in screening and follow-up patient groups.
Yeoh GP; Tse MP; Chan KW; Lord L
Acta Cytol; 2006; 50(6):627-31. PubMed ID: 17152273
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
Walboomers JM; de Roda Husman AM; Snijders PJ; Stel HV; Risse EK; Helmerhorst TJ; Voorhorst FJ; Meijer CJ
J Clin Pathol; 1995 Aug; 48(8):728-32. PubMed ID: 7560199
[TBL] [Abstract][Full Text] [Related]
19. Effect of glacial acetic acid pre-treatment of cervical liquid-based cytology specimens on the molecular detection of human papillomavirus.
Moore C; Cuschieri K; McQueen F; Duvall E; Graham C; Cubie HA
Cytopathology; 2013 Oct; 24(5):314-20. PubMed ID: 23379748
[TBL] [Abstract][Full Text] [Related]
20. [The use of HPV typing: the point of view of the virologist and the pathologist].
Bergeron C
Ann Pathol; 1999; 19(5 Suppl):S92-3. PubMed ID: 10599464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
